{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:01:24Z","timestamp":1791820884518,"version":"4.3.4"},"reference-count":26,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T00:00:00Z","timestamp":1564876800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2020,1,2]]},"DOI":"10.1080\/13696998.2019.1646263","type":"journal-article","created":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T10:46:30Z","timestamp":1563533190000},"page":"70-79","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":41,"title":["Economic burden of spinal muscular atrophy in the United States: a contemporary assessment"],"prefix":"10.1080","volume":"23","author":[{"given":"Marcus","family":"Droege","sequence":"first","affiliation":[{"name":"AveXis, Inc, Bannockburn, IL, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Sproule","sequence":"additional","affiliation":[{"name":"AveXis, Inc, Bannockburn, IL, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Arjunji","sequence":"additional","affiliation":[{"name":"AveXis, Inc, Bannockburn, IL, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolaine","family":"Gauthier-Loiselle","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Cloutier","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Dabbous","sequence":"additional","affiliation":[{"name":"AveXis, Inc, Bannockburn, IL, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,8,4]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2018.4"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-019-0568-z"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1172\/JCI121658"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.3233\/JND-180304"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2011.09.001"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1702752"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.11.004"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.11.005"},{"key":"CIT0009","unstructured":"US Food and Drug Administration. FDA approves first drug for spinal muscular atrophy. 2016. Available at: http:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm534611.htm"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1710504"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-018-0093-0"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2016.1198355"},{"key":"CIT0013","volume-title":"Economic burden of infantile-onset (type 1) spinal muscular atrophy: A retrospective claims database analysis. ISPOR 2018 (poster)","author":"Dabbous O","year":"2018"},{"key":"CIT0014","volume-title":"The economic burden of spinal muscular atrophy patients in a commercially-insured population in the United States. Academy of Managed Care Pharmacy (AMCP) Nexus 2018 (poster);","author":"Goble J"},{"key":"CIT0015","volume":"88","author":"Teynor M","year":"2017","journal-title":"Neurology"},{"key":"CIT0016","volume":"88","author":"Teynor M","year":"2017","journal-title":"Neurology"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-016-0424-0"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-017-0695-0"},{"key":"CIT0019","volume":"92","author":"Lee M","year":"2018","journal-title":"Pediatr Neurol"},{"key":"CIT0020","unstructured":"Henry J Kaiser Family Foundation. Hospital Adjusted Expenses per Inpatient Day 2018 [cited 2019 Jan 17]. Available at: https:\/\/www.kff.org\/health-costs\/state-indicator\/expenses-per-inpatient-day"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4508"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2017.4360"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1089\/pai.2009.0002"},{"key":"CIT0024","unstructured":"Novartis AG. AveXis receives FDA approval for Zolgensma\u00ae, the first and only gene therapy for pediatric patients with spinal muscular atrophy (SMA) 2019 [cited 2019 Jun 25]. Available at: https:\/\/www.novartis.com\/news\/media-releases\/avexis-receives-fda-approval-zolgensma-first-and-only-gene-therapy-pediatric-patients-spinal-muscular-atrophy-sma"},{"key":"CIT0025","unstructured":"Cure SMA. Trials currently recruiting: Cure SMA; 2019 [cited 2019 Jan 9]. Available at: http:\/\/www.curesma.org\/research\/our-strategy\/clinical-trials\/trials-currently-recruiting\/"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.152"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2019.1646263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T06:37:13Z","timestamp":1598683033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2019.1646263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,4]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,2]]}},"alternative-id":["10.1080\/13696998.2019.1646263"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2019.1646263","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-05-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}